ENDRA Life Sciences (NDRA) Return on Sales (2016 - 2018)

ENDRA Life Sciences (NDRA) has reported Return on Sales for 3 consecutive years, with 15.87% the latest figure, recorded in Q4 2018.

• In Q4 2018, Return on Sales fell 1252.0% year-over-year to 15.87%; the TTM figure through Dec 2018 stood at 15.87% (down 1571.0% YoY), while the FY2018 annual figure was 15.87%, down 1571.0% from the prior year.
• Return on Sales slipped to 15.87% in Q4 2018 per NDRA's latest filing, from 7.47% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2016 and bottomed at 15.87% in Q4 2018.
• Historically, Return on Sales has averaged 3.98% across 3 years, with a median of 1.81% in 2018.
• On a YoY basis, Return on Sales climbed as much as 1 bps in 2018 and fell as far as 1252 bps in 2018.
• ENDRA Life Sciences' Return on Sales stood at 0.01% in 2016, then plunged by 24971 bps to 3.35% in 2017, then sank by 374 bps to 15.87% in 2018.
• Business Quant data shows NDRA's Return on Sales at 15.87% in Q4 2018, 7.47% in Q3 2018, and 0.26% in Q2 2018.